Stock Trading History of Murphy James R

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Murphy James R since year 2005. The trader's CIK number is 1218893. At the time of this reporting, Murphy James R is the Chairman & CEO of Bentley Pharmaceuticals Inc . (stock ticker symbol BNT). See this page for all insider trading activities at Bentley Pharmaceuticals Inc .

Stock purchases, sales, and option exercises reported by insider *Murphy James R* since 2005.
Trade Date	Symbol	Company Name (Issuer)	Trade Type	Shares	Price ($)	Value ($)
2008-05-23	BNT	Bentley Pharmaceuticals Inc	Option Exercise	11,250	.00	0
2007-05-23	BNT	Bentley Pharmaceuticals Inc	Option Exercise	6,750	.00	0
2006-03-23	BNT	Bentley Pharmaceuticals Inc	Option Exercise	200,000	4.73	946,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Murphy James R (Chairman & CEO of Bentley Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.